DJIA 16,219.80 161.45 1.01%
NASDAQ 4,688.07 51.97 1.12%
S&P 500 1,927.62 13.77 0.72%
market minute promo

64.50 1.32 (2.09%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

TEVA $64.50 2.09%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $63.84
Previous Close $63.18
Daily Range $63.44 - $64.43
52-Week Range $47.36 - $72.31
Market Cap $54.1B
P/E Ratio 42.40
Dividend (Yield) $1.36 (1.8%)
Ex-Dividend Date
Dividend Pay Date
08/18/15
09/03/15
Volume 858,153
Average Daily Volume 6,143,842
Current FY EPS $5.30

Sector

Healthcare

Industry

Drug Makers

Teva Pharmaceutical Industries (TEVA) Description

A global pharmaceutical company, Teva develops, produces, and markets generic drugs covering all major treatment categories. Website: http://www.tevapharm.com/

News & Commentary Rss Feed

George Soros' Fund Bought Teva Pharmaceutical Industries Stock -- Again

Soros Fund Management exited Teva Pharmaceutical Industries Ltd. earlier this year, but re-entered the stock in the second quarter, according to recently filed 13Fs. Should investors take a cue from this top firm?

Teva Announces U.S. Availability of ZECUITY® (sumatriptan iontophoretic transdermal system), First a

Teva Announces U.S. Availability of ZECUITY® (sumatriptan iontophoretic transdermal system), First and Only Transdermal Patch System for the Acute Treatment of Migraine

How The Bank Of Israel Got Its Last Rate Decision Wrong

Interesting TEVA Put And Call Options For October 9th

Eli Lilly's Alimta Patent Upheld by U.S. District Court

3 Stocks Pulling The Drugs Industry Downward

Short Sellers Have Mixed Feelings on Major Pharma

Acorda (ACOR) Gets Favorable Outcome in Ampyra IPR Issue

Mylan Confirms USPTO Institutes Inter Partes Review Proceedings vs Two Copaxone 40 mg/mL Dosing Pate

Mylan Confirms USPTO Institutes Inter Partes Review Proceedings vs Two Copaxone 40 mg/mL Dosing Patents

Teva's Phase III Rejig Leaves Some Unanswered Questions

Teva's Acquisition Program A Winner

See More TEVA News...

TEVA's Top Competitors

TEVA $64.50 (2.09%)
Current stock: TEVA
JNJ $93.28 (1.29%)
Current stock: JNJ
NVS $94.65 (-0.03%)
Current stock: NVS
RHHBY $33.16 (-0.63%)
Current stock: RHHBY